Carrera Capital Advisors Takes $666,000 Position in DocuSign, Inc. (NASDAQ:DOCU)

Carrera Capital Advisors purchased a new position in shares of DocuSign, Inc. (NASDAQ:DOCU) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 10,731 shares of the company’s stock, valued at approximately $666,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DOCU. American Century Companies Inc. raised its stake in shares of DocuSign by 1.9% in the 2nd quarter. American Century Companies Inc. now owns 4,099,400 shares of the company’s stock valued at $219,318,000 after acquiring an additional 75,026 shares in the last quarter. Renaissance Technologies LLC increased its position in DocuSign by 18.3% in the 2nd quarter. Renaissance Technologies LLC now owns 3,729,314 shares of the company’s stock worth $199,518,000 after buying an additional 576,414 shares during the period. Pacer Advisors Inc. boosted its position in shares of DocuSign by 77.9% in the second quarter. Pacer Advisors Inc. now owns 3,519,969 shares of the company’s stock valued at $188,318,000 after acquiring an additional 1,541,816 shares during the period. Jericho Capital Asset Management L.P. grew its stake in shares of DocuSign by 316.6% in the first quarter. Jericho Capital Asset Management L.P. now owns 3,417,908 shares of the company’s stock worth $203,536,000 after acquiring an additional 2,597,489 shares during the last quarter. Finally, Clearbridge Investments LLC raised its stake in shares of DocuSign by 4.1% in the second quarter. Clearbridge Investments LLC now owns 2,920,842 shares of the company’s stock valued at $156,265,000 after purchasing an additional 115,616 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Allan C. Thygesen sold 7,764 shares of DocuSign stock in a transaction that occurred on Friday, November 1st. The shares were sold at an average price of $69.95, for a total transaction of $543,091.80. Following the sale, the chief executive officer now directly owns 107,825 shares in the company, valued at $7,542,358.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO Allan C. Thygesen sold 7,764 shares of the company’s stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the sale, the chief executive officer now owns 107,825 shares in the company, valued at $7,542,358.75. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Blake Jeffrey Grayson sold 9,552 shares of the business’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $68.80, for a total transaction of $657,177.60. Following the transaction, the chief financial officer now owns 78,265 shares in the company, valued at $5,384,632. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 69,558 shares of company stock valued at $4,272,768. 1.66% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of brokerages have weighed in on DOCU. Royal Bank of Canada upped their price target on DocuSign from $52.00 to $57.00 and gave the company a “sector perform” rating in a research report on Friday, September 6th. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a report on Friday, September 6th. Citigroup boosted their target price on shares of DocuSign from $86.00 to $87.00 and gave the stock a “buy” rating in a research note on Friday, September 6th. Bank of America increased their price target on shares of DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, Wells Fargo & Company boosted their price objective on shares of DocuSign from $48.00 to $50.00 and gave the stock an “underweight” rating in a research report on Friday, September 6th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, DocuSign currently has an average rating of “Hold” and an average target price of $63.40.

DocuSign Stock Up 1.5 %

Shares of DOCU stock traded up $1.18 during trading on Tuesday, reaching $82.40. The company’s stock had a trading volume of 735,536 shares, compared to its average volume of 2,880,327. The business has a fifty day moving average price of $65.20 and a 200-day moving average price of $58.85. DocuSign, Inc. has a one year low of $40.64 and a one year high of $82.54. The company has a market cap of $16.72 billion, a price-to-earnings ratio of 17.14, a price-to-earnings-growth ratio of 8.40 and a beta of 0.90.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, September 5th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.17. The firm had revenue of $736.03 million for the quarter, compared to analyst estimates of $727.20 million. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.09 earnings per share. Research analysts anticipate that DocuSign, Inc. will post 1.01 EPS for the current year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.